Diseases · Entity Annotation Prototype (beta)

15articles mentioning diseases

30disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: ALD ×

ALD

This disease is selected. Its supporting articles are shown below.

ALD15

Articles mentioning ALD

15 articles · page 2 of 2

Association of acamprosate versus gabapentinoids with liver disease progression and alcohol-related admissions in patients with alcohol use disorder

ejhpharm · abstract · 2026-01-08 · 1 matching annotations

80.0%

hepatocellular carcinoma alcoholic hepatitis Alcohol-related liver disease compensated cirrhosis decompensated cirrhosis ALD acamprosate Gabapentinoids gabapentinoid

…c hepatitis, compensated cirrhosis, decompensated cirrhosis and hepatocellular carcinoma). The secondary outcome was alcohol-related admission. A PS enc…

P19 Understanding awareness and screening practices for MASLD amongst non-gastroenterology clinicians – a national survey study

gutjnl · abstract · 2025-10-06 · 1 matching annotations

83.9%

MASLD MetALD steatotic liver disease metabolic dysfunction-associated steatotic liver disease NAFLD

… and nurse respondentsNAFLD: non-alcoholic fatty liver disease, MASLD: metabolic dysfunction-associated steatotic liver disease, MetA…

P68 An open-label phase 1/2 multicentre study to evaluate the safety, tolerability and efficacy of RTX001 autologous macrophages in participants with liver cirrhosis who have hepatic decompensation (EMERALD)

gutjnl · abstract · 2025-10-06 · 1 matching annotations

88.3%

hepatocellular carcinoma cirrhosis ALD MASLD Met-ALD steatotic liver disease G-CSF EMERALD

… a baseline MELD 3.0 score of 12–20. Exclusion criteria include hepatocellular carcinoma, portal vein thrombosis, significant hydrothorax, splenomegaly …